News and Articles

InCube in the News

Read more about InCube, Mir and our portfolio companies in the news. InCube portfolio company, Rani Therapeutics, is garnering attention for its novel approach to the oral delivery of biologics, considered the Holy Grail in Drug Delivery.

Recent Articles

Press

Fe Medical: Patch That Uses Electricity To Deliver Iron

04/11/2019
Press

Fe3 Medical: human study of electric transdermal iron patch

04/11/2019
Press

Robotic, auto-injection pill shows safety in first human trial

03/01/2019
Press

Biologics Smart-Pill Passes First-in-Human Trial

03/01/2019
Press

First-in-human safety study of its robotic biologic pill completed.

03/01/2019
Press

Robotic pill tech found to be safe, tolerable in early human study

02/28/2019
Press

First trial of capsule that could replace injections

02/28/2019
Press

Human Study of "Robotic" RaniPill™ Capsule to Replace Injections

02/28/2019
Media

Rani Therapeutics reports positive data for robotic pill

02/28/2019
Press

Fe Medical: Patch That Uses Electricity To Deliver Iron

04/11/2019
Press

Fe3 Medical: human study of electric transdermal iron patch

04/11/2019
Press

Robotic, auto-injection pill shows safety in first human trial

03/01/2019
Press

Biologics Smart-Pill Passes First-in-Human Trial

03/01/2019
Press

First-in-human safety study of its robotic biologic pill completed.

03/01/2019
Press

Robotic pill tech found to be safe, tolerable in early human study

02/28/2019
Press

First trial of capsule that could replace injections

02/28/2019
Press

Human Study of "Robotic" RaniPill™ Capsule to Replace Injections

02/28/2019
Media

Rani Therapeutics reports positive data for robotic pill

02/28/2019
Press

Shire bags option on device-enabled oral FVIII drug

12/05/2018
Press

Robotic-Pill Maker Rani Therapeutics Backed by Shire

12/05/2018
Press

Market Intel: Robotic Pills And The Future Of Painless Drug Delivery

09/13/2018
Press

PharmaVoice on Biologics (including commentary from Mir Imran)

09/07/2018
Press

Rani Therapeutics' CEO Mir Imran Selected For The 2018 Upstart 50 List

09/07/2018
Press

Swallowing A Biologic Drug?

08/27/2018
Press

Why biosimilars won’t be the only shake up in biologics

08/08/2018
Press

Mir Imran named to PharmaVOICE 100

08/06/2018
Press

The billion-dollar startups revolutionizing healthcare in 2018

07/17/2018